Nexviazyme
Payments companies reported to CMS as associated with Nexviazyme. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nexviazyme, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nexviazyme
These are the largest totals companies reported as associated with Nexviazyme. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Rogers | Greenville, SC | Clinical Genetics (M.D.) | $85,086.93 |
| Shafeeq Ladha | Phoenix, AZ | Neuromuscular Medicine (Psychiatry & Neurology) | $59,618.80 |
| Dmitriy Niyazov | Durham, NC | Clinical Genetics (M.D.) | $48,256.09 |
| Jay Han | Orange, CA | Neuromuscular Medicine (Physical Medicine & Rehabilitation) | $45,936.27 |
| Perry Shieh | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $30,192.47 |
| Bassam Malo | Fenton, MO | Neurology (Psychiatry & Neurology) | $28,984.70 |
| Alberto Santiago Cornier | Santurce, PR | Clinical Genetics (M.D.) | $24,937.88 |
| Marta Biderman Waberski | Fairfax, VA | Clinical Genetics (M.D.) | $24,021.10 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $22,389.50 |
| Priya Kishnani | Durham, NC | Pediatrics | $21,858.46 |
Prescribed Nexviazyme?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.